NCT05710211View on ClinicalTrials.gov

Clonal Architecture of ASXL1-mutated Myelofibrosis

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 24, 2023

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2031

Conditions
Myelofibrosis
Interventions
BIOLOGICAL

Clonal architecture determination

"Biological:~* Determination of clonal architecture by sorting of circulating CD34 positive cells followed by cell culture and colony genotyping and/or single-cell DNA-sequencing~* Secondary outcome: transcriptomic study by RNA-sequencing"

Trial Locations (13)

13009

RECRUITING

Institut Paoli Calmettes, Marseille

33604

RECRUITING

CHU de Bordeaux, Pessac

69495

RECRUITING

CHU Lyon, Pierre-Bénite

75010

NOT_YET_RECRUITING

AP-HP Hôpital Saint Louis, Paris

94010

RECRUITING

CHU Henri MONDOR, Créteil

Unknown

RECRUITING

CHU Angers, Angers

NOT_YET_RECRUITING

CHRU Brest, Brest

NOT_YET_RECRUITING

CH Cholet, Cholet

NOT_YET_RECRUITING

CHU Nantes, Nantes

RECRUITING

Hôpital Bicêtre, Paris

NOT_YET_RECRUITING

CH de Cornouaille, Quimper

RECRUITING

CHRU Tours - Hôpital Bretonneau, Tours

NOT_YET_RECRUITING

CH de Vannes, Vannes

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV